Integrity Coronary Stent System    

Log In
 
 

Forgot Your Password?
 


Not a member? Click here!

Long-Term Outcomes of Coronary-Artery Bypass Grafting versus Stent Implantation
3D-IVUS Analysis From the RESOLUTE Trial
Time to Treatment (and (Transport) Issues: Selection for Reperfusion Modality, and Primary Angioplasty with No On-Site Surgery
CORE 64
New Strategies and Devices to Manage Cardiogenic Shock








 

 

Grip Strength for Risk Stratification of CV Death

Reduced muscle strength may be associated with increased risk of mortality. The PURE study has indicated that reduced grip strength using the Jamar dynamometer is inversely associated with all-cause mortality, CV mortality, non-CV mortality, MI and stroke.

For more, click here

 

 

 

Renal Denervation Resurfaces

The benefits of renal denervation as a means to lower BP remain controversial. The DENERHTN is the latest prospective, open-label, randomized study indicating that renal denervation, in addition to optimal medical therapy, is associated with a reduction in ambulatory systolic BP at 6-months.


For more, click here

 

 

 

 

Outcomes of Secondary AF

Clinical outcomes of secondary AF are unknown. Data from the Framingham Heart Study Participants have indicated that secondary AF is most common following cardiothoracic surgery, non-cardiothoracic surgery, infection, and acute MI. Stroke risk and mortality were similar between those with and without secondary precipitants.

For more, click here

 

 

 

Infective Endocarditis

The trends in IE prevalence following the 2007 IE prophylaxis guidelines in the US are unknown. Data from the NIS database from 2000-2011 have indicated that IE incidence has increased in the US. Streptococcus has become the most common organism since the 2007 guideline revision. The rates of hospitalization and valve surgery for IE have not changed.

For more, click here

 

<
||
>











CRT2013
 
Prosthesis-Patient Mismatch in High Risk Patients with Severe Aortic Stenosis in a Randomized Trial of a Self-Expanding Prosthesis
- George L. Zorn, III, MD
The Risk and Extent of Neurological Events Are Equivalent for High-Risk Patients Treated With Transcatheter or Surgical Aortic Valve Replacement
- Thomas G. Gleason, MD
Valve Thrombosis After TAVR: Frequency, Clinical Recognition, and Management
- Azeem Latib, MD
TITAX-AMI Randomized Trial 5-Years Results
- Petri Tuomainen, MD
Strokes in TAVR Is it a Deal Breaker?
- Samir Kapadia, MD
CoreValve US Pivotal Trial
- John V. Conte, MD


Live Case Demonstration from Kusatsu Heart Center
Osamu Hatoh, MD
Treating CTO via Radial?
Richard R. Heuser, MD
Patient Selection for CTO Recanalization: What Are the Appropriate Criteria?
Tarek Helmy, MD
Treating CTOs: Is There Enough Evidence-Based Data or do We Need Further Randomized Clinical Trials?
Gerald S. Werner, MD, PhD
Indication for CTO PCI: Clinical Rationale and Appropriateness
J. Aaron Grantham, MD
 Click here to visit the WEBEX archives


Long-Term Outcomes of Secondary Atrial Fibrillation in the Community: The Framingham Heart Study.
S Lubitz, et al.
Circ 2015; 131:1648-1655
Intermediate Outcomes in the Prospective, Multicenter Coarctation of the Aorta Stent Trial (COAST).
J Meadows, et al.
Circ 2015; 131:1656-1664
Adverse Childhood Experiences and Blood Pressure Trajectories From Childhood to Young Adulthood: The Georgia Stress and Heart Study.
S Su, et al.
Circ 2015; 131:1674-1681
Return to Work in Out-of-Hospital Cardiac Arrest Survivors: A Nationwide Register-Based Follow-Up Study.
K Kragholm, et al.
Circ 2015; 131:1682-1690
Randomized Trial of Four Financial-Incentive Programs for Smoking Cessation.
S Halpern, et al.
NEJM 2015 Online
Interacting Resident Epicardium-Derived Fibroblasts and Recruited Bone Marrow Cells Form Myocardial Infarction Scar.
A Ruiz-Villalba, et al.
JACC 2015; 65:2057-2066
Trends in Infective Endocarditis Incidence, Microbiology, and Valve Replacement in the United States From 2000 to 2011.
S Pant, et al.
JACC 2015; 65:2070-2076
Gaps in Referral to Cardiac Rehabilitation of Patients Undergoing Percutaneous Coronary Intervention in the United States CME.
K Aragam, et al.
JACC 2015; 2079-2088
The Effect of Cardiorespiratory Fitness on Age-Related Lipids and Lipoproteins.
Y Park, et al.
JACC 2015; 65:2091-2100
Prognostic Value of Grip Strength: Findings From the Prospective Urban Rural Epidemiology (PURE) Study.
D Leong, et al.
The Lancet 2015 Online
Financing Universal Health Coverage—Effects of Alternative Tax Structures on Public Health Systems: Cross-National Modelling in 89 Low-Income and Middle-Income Countries.
A Reeves, et al.
The Lancet 2015 Online
Optimum and Stepped Care Standardised Antihypertensive Treatment With or Without Renal Denervation for Resistant Hypertension (DENERHTN): a Multicentre, Open-Label, Randomised Controlled Trial.
M Azizi, et al.
The Lancet 2015; 385:1957-1965



Poll Archives
The EGO-BioFreedom Study
Stephen WL LEE, M.D.
The CONTROL multi-center study
Israel Barbash, M.D.
The SORT OUT VII trial
Lisette Okkels Jensen, M.D.
The NOTION Trial
Lars Søndergaard, M.D., M.P.H.
Final Three-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer
Masahiro Natsuaki, M.D.
PRAGUE 13 trial
O. Hlinomaz, M.D.
The FFRCT RIPCORD Study
Curzen N., M.D.
The Reservoir Clinical Trial
Rajeev K. Pathak, M.D.

Complex Patients Today and Tomorrow: Medtronic DES solutions from Resolute Integrity to bioresorbable stents
Prof. Sigmund Silber, MD
First Report on the Pivotal DESolve Nx trial: 6-month Clinical and Multimodality Imaging Results
Alexandre Abizaid, MD, PhD
One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study
Raul Moreno, MD, et al.
Two-year clinical outcomes in the EVOLVE FHU trial
Ian Meredith, MD, PhD
BIOFLOW-II Trial
Stephan Windecker, MD, et al.

Outcomes in More Than 7000 Patients With Diabetes After Implantation of the Resolute Zotarolimus-eluting Stent
Rosli Mohd Ali, MD
Safety update and long-term clinical outcomes from all studies in the RESOLUTE Global Clinical Program
Carlo Di Mario, MD
Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial
Stephan Windecker, MD
Angina Status & TLF Creep: Bioabsorbable Stents (BAS) & Drug-Eluting Stents (DES)
Medtronic, Inc.
Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent
Stephan Windecker, MD
Four-year Outcomes from the Randomized Comparison of a Zotarolimus-eluting and an Everolimus-eluting Stent in the RESOLUTE All Comers Trial
Patrick W Serruys MD, PhD
Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program
Prof. Ran Kornowski, MD



5/15/2015
Biotronik to Distribute CFI Medical’s Zero-Gravity Weightless Radiation Protection System

5/6/2015
Teva Launches Argatroban Injection

5/6/2015
Stentys Xposition S Self-Apposing Stent Receives CE Mark Approval

5/6/2015
Enrollment Begins for Medtronic’s SYMPLICITY AF Study of Pulmonary Vein Isolation Combined With Renal Denervation to Treat Atrial Fibrillation

5/1/2015
Study Begins for Medtronic’s Endurant Evo AAA Stent Graft System

5/1/2015
Early Feasibility Study Begins for Gore TAG Thoracic Branch Endoprosthesis to Treat Aortic Arch Aneurysms

5/1/2015
Enrollment Begins for Medtronic’s SYMPLICITY AF Study of Pulmonary Vein Isolation Combined With Renal Denervation to Treat Atrial Fibrillation

4/9/2015
First US commercial procedures with the Watchman device

4/9/2015
Medtronic announces SPYRAL HTN global clinical trial programme for renal denervation

4/9/2015
CoreValve receives first TAVR valve-in-valve indication

4/1/2015
First Commercial Procedures in the United States Performed With Boston Scientific’s Watchman Device

4/1/2015
The Medicines Company’s Cangrelor Approved in Europe

4/1/2015
New Indication Allows Brilinta to Be Crushed for Patients With Difficulty Swallowing

4/1/2015
Medtronic’s CoreValve TAVR System Approved in Japan

4/1/2015
FDA Approves Valve-in-Valve Procedures With CoreValve TAVR System

3/31/2015
Medtronic CoreValve® System Receives FDA Approval for Transcatheter Valve-In-Valve Procedures

3/25/2015
ABIOMED IMPELLA 2.5 RECEIVES FDA APPROVAL FOR ELECTIVE AND URGENT HIGH RISK PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURES

3/18/2015
Infraredx Launches Advanced TVC Imaging System and TVC Muller Extended Bandwidth NIRS-IVUS Catheter

3/18/2015
Medtronic Initiates Pivotal Studies of Resolute Onyx(TM) Drug-Eluting Stent in United States

3/18/2015
Toshiba’s Infinix 4DCT Receives FDA Clearance with Aquilion PRIME CT Configuration

3/18/2015
Boston Scientific Announces Definitive Agreement To Acquire American Medical Systems' Urology Portfolio For Up To $1.65 Billion

3/10/2015
Boston Scientific to Acquire American Medical Systems’ Urology Portfolio

12/18/2014
ArtVentive Medical’s EOS Device Receives FDA Clearance

12/11/2014
CSI Completes COAST Enrollment in Japan

11/19/2014
Toshiba Enhances Radiation Dose Tracking System on Infinix

11/19/2014
Medtronic Bifurcated Endurant IIs AAA Stent Graft Launched in Europe and United States

11/11/2014
Abbott Enters Electrophysiology Market With Acquisition of Topera

10/15/2014
IDE Approved for Trial of Neovasc’s Tiara Transcatheter Mitral Valve

10/15/2014
FDA Approves Bracco Diagnostics’ Lumason Ultrasound Contrast Agent

10/15/2014
Merit Medical Unveils ThinkRadial Website and Educational Initiative

10/9/2014
Endologix Completes Enrollment in EVAS FORWARD—GLOBAL Registry of Nellix System
ACS & AMI
Angiomyogenesis & Cell Therapy
Carotid Interventions

Home | CRT2015 | CardioTube | Interesting Cases | Trials | Weekly Poll Archive | Newsletter Archive | Login


Copyright © 2015, CRTONLINE - About / Contact Us. All rights reserved. Privacy Policy
Powered by Multiweb